Ipsen to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 15, 2018

Thursday, November 8, 2018 Press Release
Email Print This Page Comment bookmark
Font : A-A+

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event

PARIS, Nov. 8, 2018 /PRNewswire/ -- Ipsen (France: IPN, OTC Pink: IPSEY) based in

Paris, and focused on Specialty Care biopharmaceuticals, today announced that Eugenia Litz, Vice President of Investor Relations, will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on November 15, 2018.  This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.

DATE: November 15, 2018TIME: 9:00 AM ETLINK: https://tinyurl.com/111415dbvicprepr

This will be a live, interactive online event where investors are invited to ask international companies their questions in real-time and to download a company's information in their "virtual trade booth" in the Exhibits section. If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

Participation is free of charge.

It is recommended that investors pre-register to save time and receive event updates.

About Ipsen

Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases. Its commitment to Oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales over €1.9 billion in 2017, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,400 employees worldwide. Ipsen is listed in Paris (Euronext: IPN) and in the United States through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information on Ipsen, visit www.ipsen.com.

Cision View original content:http://www.prnewswire.com/news-releases/ipsen-to-present-at-the-dbvic---deutsche-bank-adr-virtual-investor-conference-on-november-15-2018-300746444.html

SOURCE Ipsen



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store